...
首页> 外文期刊>Expert review of vaccines >Hydatid disease: vaccinology and development of the EG95 recombinant vaccine.
【24h】

Hydatid disease: vaccinology and development of the EG95 recombinant vaccine.

机译:包虫病:疫苗学和EG95重组疫苗的开发。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hydatid disease is a zoonotic parasitic disease that is distributed widely around the world and causes substantial human morbidity and mortality, particularly in developing countries. Reduction of human hydatid disease using anthelmintics, together with changes in human lifestyle and animal management practices, have been unsuccessful in some developing countries where the disease still persists. Substantial progress has been made towards developing a practical, recombinant vaccine in sheep, to interrupt the lifecycle of Echinococcus granulosus and to prevent subsequent transmission from dogs to humans. This review focuses on the scientific advances in the development of a recombinant vaccine for hydatid disease and the remaining challenges facing the widespread use of the vaccine for control of hydatid disease in endemic areas.
机译:d虫病是一种人畜共患性寄生虫病,在世界范围内广泛分布,并导致大量的人类发病和死亡,特别是在发展中国家。在某些仍然存在该病的发展中国家中,使用驱虫药减少人类management虫病以及人类生活方式和动物管理方法的改变一直未能成功。在绵羊中开发实用的重组疫苗,打断细粒棘球E虫的生命周期并防止随后从狗传播给人类的工作取得了实质性进展。这篇综述着重于开发用于hy虫病的重组疫苗的科学进展以及在流行地区广泛使用该疫苗控制control虫病所面临的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号